CITIGROUP INC - NAUTILUS BIOTECHNOLOGY INC ownership

NAUTILUS BIOTECHNOLOGY INC's ticker is NAUT and the CUSIP is 63909J108. A total of 83 filers reported holding NAUTILUS BIOTECHNOLOGY INC in Q4 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of NAUTILUS BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$8,298
-88.1%
2,626
-85.4%
0.00%
Q2 2023$69,505
+1025.8%
17,960
+705.7%
0.00%
Q1 2023$6,174
+27.6%
2,229
-17.0%
0.00%
Q4 2022$4,837
-19.4%
2,687
-9.9%
0.00%
Q3 2022$6,000
-57.1%
2,982
-43.5%
0.00%
Q2 2022$14,000
-68.9%
5,281
-49.2%
0.00%
Q1 2022$45,000
+95.7%
10,387
+130.3%
0.00%
Q4 2021$23,000
+228.6%
4,510
+280.6%
0.00%
Q3 2021$7,000
-41.7%
1,1850.0%0.00%
Q2 2021$12,0001,1850.00%
Other shareholders
NAUTILUS BIOTECHNOLOGY INC shareholders Q4 2021
NameSharesValueWeighting ↓
Madrona Venture Group, LLC 6,020,770$30,663,0004.08%
Ally Bridge Group (NY) LLC 1,500,000$9,210,0002.71%
AMAZON COM INC 1,457,055$8,946,0001.82%
Affinity Asset Advisors, LLC 975,000$5,987,0001.51%
Tikvah Management LLC 708,540$4,350,436,0001.18%
Perceptive Advisors 8,911,151$54,714,0000.80%
Bain Capital Life Sciences Investors, LLC 2,000,000$12,280,0000.76%
HILLMAN CO 200,000$1,228,0000.43%
SPHERA FUNDS MANAGEMENT LTD. 800,000$4,912,0000.41%
RA Capital Management 2,436,430$14,960,0000.21%
View complete list of NAUTILUS BIOTECHNOLOGY INC shareholders